Advanced search
Publication Cover
OncoImmunology Volume 3, 2014 - Issue 1
Submit an article Journal homepage
794
Views
24
CrossRef citations to date
0
Altmetric
Author's View

Melanoma hijacks plasmacytoid dendritic cells to promote its own progression

Caroline Aspord University Joseph Fourier; INSERM, U823; Immunobiology & Immunotherapy of Cancers; Grenoble, France; French Blood Service; Rhone-Alpes; R&D-Laboratory; Grenoble, FranceCorrespondence[email protected]
,
Marie-Therese Leccia University Joseph Fourier; INSERM, U823; Immunobiology & Immunotherapy of Cancers; Grenoble, France; Dermatology Department; Grenoble University Hospital; Grenoble, France
,
Julie Charles University Joseph Fourier; INSERM, U823; Immunobiology & Immunotherapy of Cancers; Grenoble, France; Dermatology Department; Grenoble University Hospital; Grenoble, France
&
Joel Plumas University Joseph Fourier; INSERM, U823; Immunobiology & Immunotherapy of Cancers; Grenoble, France; French Blood Service; Rhone-Alpes; R&D-Laboratory; Grenoble, France
Article: e27402 | Received 28 Nov 2013, Accepted 02 Dec 2013, Published online: 01 Jan 2014

References

  • Eggermont AM, Spatz A, Robert C. Cutaneous melanoma. Lancet 2013; pii: S0140-6736:60802 - 8; PMID: 24054424
  • Pinto A, Rega A, Crother TR, Sorrentino R. Plasmacytoid dendritic cells and their therapeutic activity in cancer. Oncoimmunology 2012; 1:726 - 34; http://dx.doi.org/10.4161/onci.20171; PMID: 22934264
  • Villadangos JA, Young L. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 2008; 29:352 - 61; http://dx.doi.org/10.1016/j.immuni.2008.09.002; PMID: 18799143
  • Liu C, Lou Y, Lizée G, Qin H, Liu S, Rabinovich B, Kim GJ, Wang YH, Ye Y, Sikora AG, et al. Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice. J Clin Invest 2008; 118:1165 - 75; PMID: 18259609
  • Lande R, Gilliet M. Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses. Ann N Y Acad Sci 2010; 1183:89 - 103; http://dx.doi.org/10.1111/j.1749-6632.2009.05152.x; PMID: 20146710
  • Sisirak V, Faget J, Gobert M, Goutagny N, Vey N, Treilleux I, Renaudineau S, Poyet G, Labidi-Galy SI, Goddard-Leon S, et al. Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression. Cancer Res 2012; 72:5188 - 97; http://dx.doi.org/10.1158/0008-5472.CAN-11-3468; PMID: 22836755
  • Godefroy E, Bhardwaj N. Dysregulation of anti-tumor immunity by the matrix metalloproteinase-2. Oncoimmunology 2012; 1:109 - 11; http://dx.doi.org/10.4161/onci.1.1.17994; PMID: 22720227
  • Charles J, Di Domizio J, Salameire D, Bendriss-Vermare N, Aspord C, Muhammad R, Lefebvre C, Plumas J, Leccia MT, Chaperot L. Characterization of circulating dendritic cells in melanoma: role of CCR6 in plasmacytoid dendritic cell recruitment to the tumor. J Invest Dermatol 2010; 130:1646 - 56; http://dx.doi.org/10.1038/jid.2010.24; PMID: 20220766
  • Jensen TO, Schmidt H, Møller HJ, Donskov F, Høyer M, Sjoegren P, Christensen IJ, Steiniche T. Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma. Cancer 2012; 118:2476 - 85; http://dx.doi.org/10.1002/cncr.26511; PMID: 21953023
  • Aspord C, Leccia M-T, Charles J, Plumas J. Plasmacytoid dendritic cells support melanoma progression by promoting Th2 and regulatory immunity through OX40L and ICOSL. Cancer Immunol Research 2013; 1:1 - 14

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.